Form 4: Sight Sciences CFO Alison Bauerlein Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4


Alison Bauerlein, CFO of Sight Sciences, sold 13,066 shares of common stock on May 19, 2025, to cover tax liabilities related to vesting restricted stock units.

Summary

  • On May 19, 2025, Alison Bauerlein, the Chief Financial Officer of Sight Sciences, Inc. (SGHT), sold 13,066 shares of the company's common stock.
  • The sale was executed at a price of $3.477 per share.
  • The transaction was conducted to cover the reporting person's tax liability associated with the vesting of restricted stock units.
  • Following the transaction, Bauerlein still beneficially owns 636,728 shares of Sight Sciences common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider stock sale to cover tax obligations. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of insider trading activity and are used to disclose transactions by company insiders. This transaction is not necessarily indicative of the company's overall performance or future prospects.

Stakeholder Impact

  • The sale of shares by a company insider could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on the company's operations or financial performance.

Key Dates

DateDescription
05/19/2025Date of stock sale transaction.
05/21/2025Date of signature on the Form 4 filing.

Keywords

Sight Sciences, SGHT, Alison Bauerlein, CFO, Form 4, Stock Sale, Restricted Stock Units, Tax Liability, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.